Kleinfeld Kaplan & Becker LLP Announces Election of T. Daniel Logan as Partner

Audio By Carbonatix

WASHINGTON--(BUSINESS WIRE)--Dec 31, 2024--

Kleinfeld Kaplan & Becker LLP (KKB) is pleased to announce that T. Daniel “Dan” Logan has been elected to the partnership effective January 1, 2025. Mr. Logan’s practice focuses on advising and representing clients regulated by the U.S. Food and Drug Administration (FDA) in the food, cosmetic, drug, dietary supplement, and tobacco industries on regulatory compliance and advertising law matters.

Prior to joining KKB as an associate in 2018, he served as Associate Chief Counsel at the FDA’s Office of the Chief Counsel, where Dan advised subject matter experts, assessed evidence and policy rationales, and developed legal interpretations relating to the FDA’s regulatory objectives. Additionally, during his time at the FDA, he worked with the Center for Tobacco Products and directed the center on rulemakings, program development, calculation and assessment of user fees, premarket review of tobacco products, and enforcement strategies. Dan also served as counsel for the FDA for investigations conducted by the Government Accountability Office and Office of the Inspector General of the Department of Health and Human Services.

“Dan’s broad range of skills, diverse experiences, and deep client relationships position him exceptionally well for making significant contributions to the partnership and the broader FDA bar for many years,” said Will Woodlee, KKB's managing partner. “His promotion will further strengthen our firm’s position among the most comprehensive FDA regulatory and advertising practices in the country.”

Mr. Logan earned his J.D. (cum laude) from the Indiana University Maurer School of Law. He is a member of the bars of the District of Columbia and Maryland. Mr. Logan can be reached at [email protected] or (202) 223-5120.

Kleinfeld Kaplan & Becker LLP is a Washington DC boutique law firm that has focused on food-and-drug and advertising law issues for over 60 years. The firm’s practice concentrates on the regulation of products subject to the jurisdiction of the U.S. Food and Drug Administration — food, drugs & biologics, cosmetics, medical devices, dietary supplements, and tobacco products — as well as advertising laws and other laws regulating consumer products and services. The practice also covers many related areas, including: regulation of controlled substances; meat, poultry, and egg products; Medicare and Medicaid reimbursement, price reporting, and compliance issues; unfair trade practice investigations; alcoholic beverages; and cannabis.For more information, visitwww.kkblaw.com, call 202-223-5120, or email[email protected].

View source version on businesswire.com:https://www.businesswire.com/news/home/20241231613185/en/

CONTACT: www.kkblaw.com

202-223-5120

[email protected]

KEYWORD: DISTRICT OF COLUMBIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES

SOURCE: Kleinfeld Kaplan & Becker LLP

Copyright Business Wire 2024.

PUB: 12/31/2024 07:43 PM/DISC: 12/31/2024 07:42 PM

http://www.businesswire.com/news/home/20241231613185/en